Skip metastases to the axillary lymph nodes in breast cancer
Citation, DOI, disclosures and article data
At the time the article was created Israel Rodriguez-Suarez had no recorded disclosures.View Israel Rodriguez-Suarez's current disclosures
At the time the article was last revised Israel Rodriguez-Suarez had no recorded disclosures.View Israel Rodriguez-Suarez's current disclosures
Skip metastases to the axillary lymph nodes in breast cancer refer to the uncommon phenomenon in which metastases do not follow the conventional stepwise pattern from level I to level II, to level III (infraclavicular), to the supraclavicular fossa, and or internal jugular chain 1-6,9.
On this page:
Axillary lymph nodes are surgically divided according to their location relative to the pectoralis minor muscle:
- level I: lateral and inferior.
- level II: underneath the muscle.
- level III (infraclavicular): medial and superior.
Rotter nodes are located between the pectoralis major and minor muscles and are considered at level II.
It is widely accepted that the malignant infiltration of axillary lymph nodes follows this sequence, to supraclavicular fossa and or internal jugular chain.
Skip metastases to the axillary lymph node in breast cancer has been reported to happen in 1.3% to 14.6% of patients in some series 1-6,9.
In the review of four series 1,5,6,9, 1576 patients had axillary lymph node metastases, of this, 74 had skip metastases, with the most frequent pattern: level I skipped to level III (22), level I skipped to supraclavicular (18), and when level I was not affected the most frequent metastasis was to level II (15 patients).
The modality of choice for evaluating the axilla, when scanning is safe to stop if the first level is free of disease; and if it is abnormal, because the eighth edition of The American Joint Committee on Cancer staging manual considers level I and II together you can go for the infraclavicular level instead of level II. Stage IIIC includes positive lymph nodes in the infraclavicular fossa (level III), or internal mammary chain plus axilla, or supraclavicular nodes, thus cannot be missed in the evaluation 7,8.
As good practice, you can examine the infra (III) and supraclavicular fossa if the level I nodes are suspicious. You should never forget to scan the internal mammary nodal basins.
In a study of 539 cases treated with total axillary dissection, Veronesi et. al 1, stated that the predictive value of the first level is considerable; when lymph nodes at level one are negative, the probability that infiltrating nodes are present at the second and third levels is minimal. When the nodes at the first level are positive, the chances that metastases are also present at the higher levels are of the order of 40% 1.
- 1. Veronesi U, Rilke F, Luini A, Sacchini V, Galimberti V, Campa T, Dei Bei E, Greco M, Magni A, Merson M. Distribution of axillary node metastases by level of invasion. An analysis of 539 cases. (1987) Cancer. 59 (4): 682-7. doi:10.1002/1097-0142(19870215)59:4<682::aid-cncr2820590403>3.0.co;2-z - Pubmed
- 2. Veronesi U, Luini A, Galimberti V, Marchini S, Sacchini V, Rilke F. Extent of metastatic axillary involvement in 1446 cases of breast cancer. (1990) European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 16 (2): 127-33. Pubmed
- 3. Wang H, Mao XY, Zhao TT, Zheng XY, Jin F, Li JG. Study on the skip metastasis of axillary lymph nodes in breast cancer and their relation with Gli1 expression. (2012) Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 33 (6): 1943-50. doi:10.1007/s13277-012-0455-7 - Pubmed
- 4. Sun J, Yin J, Ning L, Liu J, Liu H, Gu L, Fu L. Clinicopathological characteristics of breast cancers with axillary skip metastases. (2012) Journal of investigative surgery : the official journal of the Academy of Surgical Research. 25 (1): 33-6. doi:10.3109/08941939.2011.598605 - Pubmed
- 5. Khafagy M, Mostafa A, Fakhr I. Distribution of axillary lymph node metastases in different levels and groups in breast cancer, a pathological study. (2011) Journal of the Egyptian National Cancer Institute. 23 (1): 25-30. doi:10.1016/j.jnci.2011.07.004 - Pubmed
- 6. Rosen PP, Lesser ML, Kinne DW, Beattie EJ. Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections. (1983) Annals of surgery. 197 (3): 276-83. doi:10.1097/00000658-198303000-00006 - Pubmed
- 7. Basset, L. (2011). Breast Imaging, 1st Edition. USA. Saunders.
- 8. Harvey J, March D. (2013). Making the Diagnosis: A Practical Guide to Breast Imaging, 1st Edition. USA. Saunders.
- 9. Chung H, Sun J, Leung JWT. Breast Cancer Skip Metastases: Frequency, Associated Tumor Characteristics, and Role of Staging Nodal Ultrasound in Detection. (2020) AJR. American journal of roentgenology. doi:10.2214/AJR.20.24371 - Pubmed